The global cannabidiol market is projected at $24.61 billion in 2026, according to Fortune Business Insights, with forecasts reaching as high as $382 billion by 2034 at a 40.89% CAGR. This article covers the latest cannabidiol market statistics for 2026, including market size estimates across research firms, segment breakdowns, regional revenue splits, and recent regulatory developments shaping the industry.
Cannabidiol Market Statistics in 2026 – TL;DR
The cannabidiol market in 2026 ranges from $10.68 billion to $30.21 billion depending on which research firm you ask, with the gap explained by different product scope definitions.
Fortune Business Insights projects the CBD market at $24.61 billion in 2026 with the highest CAGR of any firm at 40.89% through 2034.
North America holds between 46.55% and 85.80% of global CBD revenue, and the United States alone is projected at $9.78 billion in 2026.
Oils and tinctures account for 37.48% of product form revenue, while pharmaceuticals hold 36.9% of application revenue.
Asia Pacific is the fastest-growing CBD region across all research firms, with Mordor Intelligence recording a 19.74% CAGR through 2031.
How Big Is the Global Cannabidiol Market in 2026?
That depends on who you ask. Fortune Business Insights puts the 2026 figure at $24.61 billion. Market Research Future, using the broadest product definition (food, beverage, personal care, veterinary), valued the market at $27.09 billion in 2024 and $30.21 billion in 2025. Grand View Research, which counts only finished CBD-specific products like pure oils and isolates, recorded $10.68 billion for 2025.
The 3x gap between Grand View Research and Market Research Future for the same base year comes down to what counts as a CBD product. Broader scopes that include CBD-infused beverages, cosmetics, and pet care push the number much higher.
CBD Market Size Estimates by Research Firm
| Research Firm | 2024/2025 Value | Forecast End Value | CAGR |
|---|---|---|---|
| Fortune Business Insights | $16.52B (2025) | $382.04B (2034) | 40.89% |
| Market Data Forecast | $26.25B (2025) | $140.2B (2033) | 23.3% |
| Market Research Future | $30.21B (2025) | $89.89B (2035) | 11.52% |
| Grand View Research | $10.68B (2025) | $30.96B (2033) | 13.70% |
| Straits Research | $13.14B (2025) | $51.43B (2033) | 18.6% |
| Technavio | — | +$56.5B growth (2024–29) | 24.8% |
Cannabidiol Market Statistics by Product Segment
Oils and tinctures held the largest product form share at 37.48% in 2025, according to Mordor Intelligence. Gummies and confectionery posted the fastest growth at a 29.35% CAGR through 2031. On the application side, pharmaceuticals accounted for 36.9% of revenue in 2026 per Fortune Business Insights, and Grand View Research confirmed the same segment as the largest in 2025.
Retail stores captured 46.02% of distribution revenue in 2025, but e-commerce is the fastest-growing channel at a 21.86% CAGR through 2031. The B2B segment held the largest sales type share in 2025.
| Segment | Detail | Share / Growth |
|---|---|---|
| Oils & tinctures | Largest product form | 37.48% (2025) |
| Gummies & confectionery | Fastest-growing form | 29.35% CAGR to 2031 |
| Pharmaceuticals | Largest application | 36.9% (2026) |
| Retail stores | Largest distribution channel | 46.02% (2025) |
| E-commerce | Fastest-growing channel | 21.86% CAGR to 2031 |
| Marijuana-derived | Dominant source (Fortune scope) | 56.07% (2026) |
| Hemp-derived | Dominant source (GVR scope) | Largest in B2B/retail |
Cannabidiol Market Statistics by Region
North America is the largest regional market by every measure, though the exact share varies wildly. Grand View Research places it at 85.80%, while Fortune Business Insights and Mordor Intelligence both land near 47%. The difference traces back to the same scope issue: Grand View’s narrower product focus makes the US-dominated pharmaceutical and wellness markets look proportionally larger.
Fortune Business Insights values the US CBD market at $9.78 billion in 2026, with a long-term projection of $78.74 billion by 2032. Europe recorded $4.22 billion in 2025, led by the UK ($1.76 billion projected for 2026) and Germany ($1.19 billion). The pharmaceutical sector’s growth in these markets closely tracks broader regulatory changes across the region.
| Region | 2025 Value | 2026 Projected | Share |
|---|---|---|---|
| North America | $7.87B | $11.8B | 47.63% |
| Europe | $4.22B | $6.28B | 25.52% |
| Asia Pacific | $2.88B | $4.28B | 17.47% |
| Latin America | $0.90B | $1.32B | 5.42% |
| Middle East & Africa | $0.65B | $0.93B | 3.96% |
Asia Pacific: Fastest-Growing CBD Region
Every major research firm — Grand View Research, Mordor Intelligence, Fortune Business Insights, and Straits Research — agrees that Asia Pacific is the fastest-growing CBD region. Mordor Intelligence pegs the CAGR at 19.74% through 2031. China is projected at $1.84 billion in 2026, Japan at $1.1 billion, and India at $0.46 billion. Thailand became the first Southeast Asian country to legalize cannabis for medical use in 2019, and China’s expanding cosmetics market continues to pull CBD demand higher across the region.
Key CBD Market Regulatory Events in 2025
The FDA approved Epidiolex for tuberous sclerosis complex in March 2025. This is distinct from the drug’s original 2018 approval for two forms of epilepsy and confirms an expansion of prescription CBD’s approved conditions. That approval directly supports the pharmaceutical segment’s position as the top application category.
In September 2025, the UK Food Standards Agency opened a consultation on approving the first CBD food products as novel foods, covering three applications and proposing safety warnings. On the corporate side, Canopy Growth raised $300 million through convertible debenture financing in November 2024, and Aurora Cannabis partnered with Vectura and Fertin Pharma to develop the LUO CBD lozenge in September 2024.
What Explains the CBD Market CAGR Spread?
The range from 11.52% (Market Research Future) to 40.89% (Fortune Business Insights) is the widest CAGR spread in this research series. Higher base values paired with lower CAGRs produce terminal values around $89.89 billion by 2035. Lower base values with higher CAGRs reach $382 billion by 2034. Both are internally consistent — they just start from different definitions and apply different regulatory assumption models. Fortune’s higher CAGR captures the period when regulatory changes across Asia, the Middle East, and parts of Europe are expected to open currently restricted markets. Social commerce and direct-to-consumer channels are also expected to accelerate CBD adoption, particularly among younger demographics.
FAQs
How big is the global cannabidiol market in 2026?
Fortune Business Insights projects the global CBD market at $24.61 billion in 2026, growing at a 40.89% CAGR through 2034. Estimates vary by firm due to different product scope definitions.
Which region leads the cannabidiol market?
North America leads with 46–86% of global CBD revenue depending on the source. The US alone is projected at $9.78 billion in 2026 per Fortune Business Insights.
What is the fastest-growing CBD product segment?
Gummies and confectionery recorded the fastest product growth at a 29.35% CAGR through 2031, according to Mordor Intelligence’s January 2026 report.
Which region is growing fastest in the CBD market?
Asia Pacific is the fastest-growing region across all research firms. Mordor Intelligence recorded a 19.74% CAGR through 2031, driven by China, Japan, and Thailand.
What was the most recent FDA CBD approval?
The FDA approved Epidiolex for tuberous sclerosis complex in March 2025, expanding the drug’s approved conditions beyond its original 2018 epilepsy indications.
Sources:
https://www.fortunebusinessinsights.com/cannabidiol-cbd-market-103215
https://www.marketresearchfuture.com/reports/cbd-market-8090
https://www.polarismarketresearch.com/industry-analysis/cannabidiol-market
